| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Microorganisms | |
| #3 | Therapeutic chemical compounds | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Simonson Oscar | 14 |
| #2 | Grinnemo Karl-Henrik | 13 |
| #3 | Corbascio Matthias | 9 |
| #4 | Wärdell Eva | 4 |
| #5 | Sylvén Christer | 4 |
| #6 | Johansson Henrik | 3 |
| #7 | Le Blanc Katarina | 3 |
| #8 | Kumagai Makiko | 3 |
| #9 | Sylven Christer | 2 |
| #10 | Waerdell Eva | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2019112578A1 | Derivation and Self-Renewal of Multipotent Cells and Uses Thereof | |
| EP3091991A1 | Immunomodulatory compositions | |
| WO2015076717A2 | Mscs in the treatment of cardiac disorders | |
| EP3027738A2 | Mscs in the treatment of inflammatory pulmonary diseases | |
| WO2014011095A1 | Derivation and self-renewal of isi1+ cells and uses thereof |